Covid cases are currently increasing during the summer, and health experts predict an additional surge of cases in the upcoming winter months. The situation involves pharmacists’ capacity to administer Covid vaccinations, which frequently depend on the recommendations of the Advisory Committee on Immunization Practices (ACIP).
This past spring, the federal initiative aimed at ensuring updated Covid vaccines would be ready by fall seemed to be progressing smoothly. An advisory committee from the Food and Drug Administration made key decisions to address the upcoming vaccine updates. They identified which recent virus strains the new vaccines should target.
The FDA adopted the committee’s new guidelines and conveyed these to vaccine manufacturers. This coordinated effort is crucial to managing future waves of the virus effectively and ensuring public health preparedness.
Orland Park to Host New Northwestern Medicine Cancer Facility 
Study Links Occupational Cancer Risks to Flight Personnel 
How to Choose Clothing for Hot Weather: The Science Behind Staying Cool 
Battling Unexpected Cancer Despite a Smoke-Free Life 
Complex Factors Behind U.S. Prescription Drug Price Drop 
New Technique in CAR-T Therapy Targets Solid Tumors